Lysogene: LYSOGENE : Inside Information / Operations of the issuer (acquisitions, sales...)

(marketscreener.com) PRESS RELEASE Lysogene announces the request for the opening of a safeguard proceeding Paris, France - 6 December 2022 - Lysogene , a phase 3 gene therapy platform Company targeting central nervous system diseases, today announces the request for the opening of a...https://www.marketscreener.com/quote/stock/LYSOGENE-33951021/news/LYSOGENE-Inside-Information-Operations-of-the-issuer-acquisitions-sales--42490245/?utm_medium=RSS&utm_content=20221206